Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,240 public trials 1,176 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Recruiting

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

NCT07154706

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCLA Los Angeles, California, United States
  • UCI Chao Family Comprehensive Cancer Center Orange, California, United States
  • Georgetown University Medical Cener (GUMC) Washington D.C., District of Columbia, United States
  • Advent Health Orlando, Florida, United States
View all 33 locations
View Trial Details
Recruiting

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

NCT05431270

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Sarah Cannon Research Institute University of Oklahoma Oklahoma City, Oklahoma, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

NCT07094204

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +24 more
Locations
  • UCLA Santa Monica Hematology Oncology Santa Monica, California, United States
  • Winship Cancer Institute at Emory University Atlanta, Georgia, United States
  • Ochsner Health Jefferson, Louisiana, United States
  • START Midwest Grand Rapids, Michigan, United States
View all 20 locations
View Trial Details
Recruiting

A Study of Ivonescimab in People With Non-Small Cell Lung Cancer

NCT07594522

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

MYLUNG Consortium Part 3: Observational Study

NCT05885698

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Southern Cancer Center, PC Daphne, Alabama, United States
  • Arizona Oncology Associates, PC - NAHOA Prescott Valley, Arizona, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Cancer Care Centers of Brevard, Inc. Palm Bay, Florida, United States
View all 17 locations
View Trial Details
Recruiting

Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.

NCT06431633

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • Hospital General de Elche Elche, Alicante, Spain
  • ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Universitari Vall d' Hebron Barcelona, Spain
View all 32 locations
View Trial Details

Related conditions